Immunome Balance Sheet
NASDAQ: IMNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Immunome financial position
At the end of fiscal 2025, Immunome reported total assets of $683.2 million, up 184.4% from a year earlier against total liabilities of $48.8 million. Shareholders' equity stood at $634.3 million, or 92.9% of assets. The company held $653.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 14.69, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Immunome balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 653.48M | 143.35M | 98.68M | 20.32M | 49.23M | 39.77M | 2.54M |
| Short-Term Investments | 0 | 73.95M | 39.46M | — | — | — | — |
| Total Current Assets | 660.78M | 221.34M | 144.70M | 22.65M | 56.64M | 42.89M | 3.12M |
| Property, Plant & Equipment | 14.64M | 10.11M | 2.07M | 681.00K | 855.00K | 1.53M | 1.70M |
| Total Assets | 683.19M | 240.24M | 148.54M | 24.05M | 57.92M | 44.52M | 5.06M |
| Accounts Payable | 3.34M | 14.19M | 3.31M | 2.40M | 3.08M | 1.19M | 548.00K |
| Short-Term Debt | — | — | — | — | — | 366.00K | — |
| Total Current Liabilities | 44.99M | 54.31M | 21.83M | 7.33M | 9.73M | 3.04M | 1.67M |
| Long-Term Debt | — | — | — | — | — | 134.00K | — |
| Total Liabilities | 48.84M | 59.08M | 28.66M | 7.39M | 9.74M | 3.18M | 1.80M |
| Shareholders' Equity | 634.34M | 181.16M | 119.88M | 16.65M | 48.19M | 41.34M | -35.63M |
| Retained Earnings | -728.16M | -515.77M | -222.81M | -116.00M | -79.11M | -54.39M | -36.56M |
| Total Debt | — | — | — | — | — | 500.00K | — |
| Net Cash (Debt) | 653.48M | 217.30M | 138.14M | 20.32M | 49.23M | 39.27M | 2.54M |
| Shares Outstanding | 113.13M | 64.46M | 43.25M | 12.13M | 12.11M | 10.63M | 1.10M |
This table shows 7 annual periods of Immunome's balance sheet, from FY 2025 back to FY 2019, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow IMNM's reporting calendar. What is a balance sheet?